4/A: Hims & Hers Health Officer Amends Filing for Share Sale Correction

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., filed an amended Form 4 to correct the reported sale of 5,400 Class A Common Shares on June 10, 2025, at a price of $57 per share.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), filed an amended Form 4 (Form 4/A) on June 17, 2025.
• The amendment was made to correct the previously reported amount of Class A Common Shares sold on June 10, 2025.
• The corrected amount of Class A Common Shares sold is 5,400.
• These shares were sold at a price of $57 per share.
• Following this transaction, Mr. Chi directly beneficially owns 256,580 Class A Common Shares.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on March 4, 2025.

Sentiment

Score: 5

Explanation: The filing reports an insider share sale, which was pre-planned under a Rule 10b5-1 plan, and an amendment to correct the reported amount. This type of transaction is generally neutral in terms of company sentiment as it relates to personal financial planning rather than operational performance or strategic shifts.

Negatives

• An insider (Chief Commercial Officer Michael Chi) sold 5,400 shares of Class A Common Stock. While part of a 10b5-1 plan, insider sales can sometimes be perceived negatively by investors as they might suggest the insider believes the stock is fully valued or that they need liquidity.

Risks

• Potential for negative investor sentiment due to an insider share sale, even if pre-planned, as it might be misinterpreted as a lack of confidence in the company's future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, though the impact is mitigated by the disclosure that it was part of a pre-arranged 10b5-1 plan. The amendment ensures accurate public record of the transaction.

Key Dates

Keywords

Hims & Hers Health, HIMS, SEC Form 4/A, Insider Trading, Share Sale, Michael Chi, Chief Commercial Officer, 10b5-1 Plan, Beneficial Ownership, Class A Common Stock